. Author manuscript; available in PMC: 2019 Jun 27.

Published in final edited form as: J Allergy Clin Immunol. 2014 Dec 18;135(5):1199–206.e1-11. doi: 10.1016/j.jaci.2014.10.042

Table E3. Absolute risks for onset of AR_bp at 8 or 16 years of age in relation to IgE reactivity to PR-10 proteins among asymptomatic children at 4 and 8 years of age, respectively.

		Incident AR_bp at age 8 or 16 y			No onset of symptoms at age 8 or 16 y

		No.	Percent	95% CI	No.	Percent
4 y (n = 740)^*	No.	n = 86			n = 608

No IgE reactivity	659	74	11.2		585	88.8

Bet v 1 only	23	12	52.2	30.6-73.2	11	47.8

Bet v 1 + any PR-10 protein	58	46	79.3	66.6-88.8	12	20.7

Bet v 1 + Mal d 1	48	40	83.3	69.8-92.5	8	16.7

Bet v 1 + Cor a 1.04	54	42	77.8	64.4-88.0	12	22.2

Bet v 1 + Ara h 8	22	19	86.4	65.1-97.1	3	13.6

Bet v 1 + Pru p 1	19	16	84.2	60.4-96.6	3	15.8

Bet v 1 + Aln g 1	26	22	84.6	65.1-95.6	4	15.4

Bet v 1 + Api g 1	6	6	100	54.1-100	0	0

Bet v 1 + Act d 8	2	2	100	15.8-100	0	0

Bet v 1 + Gly m 4	14	13	92.9	66.1-99.8	1	7.1

			Incident AR_bp at age 16 y

8 y (n = 656)^†	No.	n = 65			n = 591

No IgE reactivity	590	36	6.1	4.3-8.3	554	93.9

Bet v 1 only	21	9	42.9	21.8-66.0	12	57.1

Bet v 1 + any PR-10 protein	45	20	44.4	29.6-60.0	25	55.6

Bet v 1 + Mal d 1	41	18	43.9	28.4-60.3	23	56.1

Bet v 1 + Cor a 1.04	37	18	48.6	31.9-65.6	19	51.4

Bet v 1 + Ara h 8	20	10	50.0	27.2-72.8	10	50.0

Bet v 1 + Pru p 1	17	9	52.9	27.8-77.0	8	47.1

Bet v 1 + Aln g 1	12	7	58.3	27.7-84.8	5	41.7

Bet v 1 + Api g 1	5	3	60.0	14.7-94.7	2	40.0

Bet v 1 + Act d 8	2	2	100	15.8-100	0	0

Bet v 1 + Gly m 4	5	2	40.0	5.3-85.3	3	60.0

No symptoms of AR_bp reported at age 4 years.

^†

No symptoms of AR_bp reported at age 4 or 8 years.

Table E3. Absolute risks for onset of ARbp at 8 or 16 years of age in relation to IgE reactivity to PR-10 proteins among asymptomatic children at 4 and 8 years of age, respectively.